Education
About Us
Working with TipRanks
Follow Us
Argent Biopharma Ltd (RGTLF)
:RGTLF
RGTLF Stock Chart & Stats
$0.09
$0.00(0.00%)
At close: 4:00 PM EST
$0.09
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.36
Previous CloseN/A
Volume49.00
Average Volume (3M)841.00
Market Cap
$4.31M
Enterprise Value$13.11M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.96
Next Earnings
Feb 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding77,768,870
10 Day Avg. Volume2,350
30 Day Avg. Volume841
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap3.04
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Argent Biopharma News
RGTLF FAQ
What was Argent Biopharma Ltd’s price range in the past 12 months?
Argent Biopharma Ltd lowest stock price was $0.01 and its highest was $0.36 in the past 12 months.
What is Argent Biopharma Ltd’s market cap?
Argent Biopharma Ltd’s market cap is $4.31M.
When is Argent Biopharma Ltd’s upcoming earnings report date?
Argent Biopharma Ltd’s upcoming earnings report date is Feb 27, 2026 which is in 127 days.
How were Argent Biopharma Ltd’s earnings last quarter?
Argent Biopharma Ltd released its earnings results on Aug 28, 2025. The company reported -$0.052 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.052.
Is Argent Biopharma Ltd overvalued?
According to Wall Street analysts Argent Biopharma Ltd’s price is currently Overvalued.
Does Argent Biopharma Ltd pay dividends?
Argent Biopharma Ltd does not currently pay dividends.
What is Argent Biopharma Ltd’s EPS estimate?
Argent Biopharma Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Argent Biopharma Ltd have?
Argent Biopharma Ltd has 77,768,870 shares outstanding.
What happened to Argent Biopharma Ltd’s price movement after its last earnings report?
Argent Biopharma Ltd reported an EPS of -$0.052 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Argent Biopharma Ltd?
Currently, no hedge funds are holding shares in RGTLF
Argent Biopharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-75.83%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-77.55%
Trailing 12-Months
Company Description
Argent Biopharma Ltd
MGC Pharmaceuticals Ltd is a European-based specialist Medical Cannabis company, in Phytocannabinoid-based medicine within the biopharmaceutical industry. The company's principal business goal is to produces and supply quality Cannabinoid based pharmaceutical products for the emergent medical markets in Europe, North America and Australasia.
Technical Analysis
Genetic Technologies
―
Zelira Therapeutics
―
EVE Health Group Limited
―
Adherium Ltd.
―
Bio-Gene Technology Ltd.
―
Ownership Overview
Options Prices
Currently, No data available
---